Compare RGEN & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGEN | PNFP |
|---|---|---|
| Founded | 1981 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.1B |
| IPO Year | N/A | N/A |
| Metric | RGEN | PNFP |
|---|---|---|
| Price | $163.80 | $99.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 15 |
| Target Price | ★ $170.90 | $112.29 |
| AVG Volume (30 Days) | 778.3K | ★ 892.6K |
| Earning Date | 10-28-2025 | 01-20-2026 |
| Dividend Yield | N/A | ★ 0.99% |
| EPS Growth | N/A | ★ 49.26 |
| EPS | 0.03 | ★ 7.83 |
| Revenue | $707,890,000.00 | ★ $1,885,186,000.00 |
| Revenue This Year | $17.84 | $31.05 |
| Revenue Next Year | $12.57 | $121.72 |
| P/E Ratio | $6,437.16 | ★ $12.36 |
| Revenue Growth | 11.74 | ★ 21.58 |
| 52 Week Low | $102.97 | $81.57 |
| 52 Week High | $182.52 | $127.85 |
| Indicator | RGEN | PNFP |
|---|---|---|
| Relative Strength Index (RSI) | 54.87 | 74.95 |
| Support Level | $160.11 | $92.53 |
| Resistance Level | $170.40 | $94.49 |
| Average True Range (ATR) | 5.38 | 2.20 |
| MACD | -0.85 | 0.92 |
| Stochastic Oscillator | 44.68 | 94.95 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.